Vimarsana
Biggest News Aggregation in the World

Page 42 - Repurchase Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repurchase Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repurchase Program Today - Breaking & Trending Today

Investegate |Carnival PLC Announcements | Carnival PLC: Final Results - Vimarsana News

Investegate |Carnival PLC Announcements | Carnival PLC: Final Results

Investegate announcements from Carnival PLC, Final Results

Atlantic Union Bankshares Corporation Announces $100 million Share Repurchase Authorization - Vimarsana News

Atlantic Union Bankshares Corporation Announces $100 million Share Repurchase Authorization

10.12.2021 - RICHMOND, Va., Dec. 10, 2021 (GLOBE NEWSWIRE) - The Board of Directors (the “Board”) of Atlantic Union Bankshares Corporation (the “Company”) has authorized the repurchase of up to $100 million worth of the Company’s common stock through December ...

PVH Corp. Reports 2021 Third Quarter Earnings Above Guidance and Raises Full Year EPS Outlook - Vimarsana News

PVH Corp. Reports 2021 Third Quarter Earnings Above Guidance and Raises Full Year EPS Outlook

Third quarter revenue increased 10% to $2.333 billion compared to the prior year period, despite worsening logistics disruptions in October, including significant U.S. port delays, which resulted in... | December 1, 2021

Walker & Dunlop Reports 35% Growth in Net Income and 60% Growth in Adjusted EBITDA on Revenues of $346 Million - Vimarsana News

Walker & Dunlop Reports 35% Growth in Net Income and 60% Growth in Adjusted EBITDA on Revenues of $346 Million

/PRNewswire/ -- THIRD QUARTER 2021 HIGHLIGHTS Record total transaction volume of $18.5 billion, up 120% from Q3'20 Total revenues of $346.3 million, up 40%...

BridgeBio Pharma Reports Third Quarter 2021 Financial Results and Business Update - Vimarsana News

BridgeBio Pharma Reports Third Quarter 2021 Financial Results and Business Update

/PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and...